Roche Molecular Systems VP of Risk Salaries in Boulder | Comparably
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on read more
EMPLOYEE
PARTICIPANTS
15
TOTAL
RATINGS
176

Roche Molecular Systems VP of Risk Salaries in Boulder

The average Roche Molecular Systems VP of Risk in Boulder earns an estimated $146,833 annually. Roche Molecular Systems' VP of Risk compensation is $3,878 more than the US average for a VP of Risk.

In Boulder, The Legal Department at Roche Molecular Systems earns $5,058 more on average than the HR Department.

Last updated 2 years ago.

$46k
$85k
$116k
$143k
$194k
$250k
$146,833
Average Compensation
$146,833
avg. base

VP of Risk Salaries at Roche Molecular Systems

In Boulder, VPs of Risk earn $748 more than Corporate Counsels, and $65,506 less than General Counsels.

General Counsel
$212k*
Corporate Counsel
$146k*
Contracts Specialist
$90k*
Paralegal
$70k*
* estimated salary

Compensation at Roche Molecular Systems by Department

In Boulder, The Legal Department averages $5,058 more than the HR Department, and $66 less than the Design Department

Design
$115,899 Avg. total comp.
+$66
Legal
$115,833 Avg. total comp.
HR
$110,775 Avg. total comp.
-$5k

VP of Risk Compensation by Gender (All Companies)

The average female VP of Risk at companies similar size to Roche Molecular Systems reported making $104,000, while the average male VP of Risk at similar sized companies reported making $157,000.

VP of Risk Compensation by Ethnicity (All Companies)

The average Hispanic or Latino VP of Risk at companies similar size to Roche Molecular Systems reported making $160,000, while the average Caucasian VP of Risk at similar sized companies reported making $132,000.

How VPs of Risk at Roche Molecular Systems Rate Their Compensation

The majority of VPs of Risk at Roche Molecular Systems believe they're compensated fairly. 100% of VPs of Risk at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems

×
Rate your company